Review



ag825  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Tocris ag825
    Ag825, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag825/product/Tocris
    Average 93 stars, based on 18 article reviews
    ag825 - by Bioz Stars, 2026-04
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress ag825
    Ag825, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag825/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ag825 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Tocris ag825
    Ag825, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag825/product/Tocris
    Average 93 stars, based on 1 article reviews
    ag825 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology erbb2 inhibitor ag825
    Erbb2 Inhibitor Ag825, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erbb2 inhibitor ag825/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    erbb2 inhibitor ag825 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Millipore ag825 (erb2 inhibitor
    Ag825 (Erb2 Inhibitor, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag825 (erb2 inhibitor/product/Millipore
    Average 90 stars, based on 1 article reviews
    ag825 (erb2 inhibitor - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology ag825
    Ag825, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag825/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    ag825 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Millipore ag825
    Ag825, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ag825/product/Millipore
    Average 90 stars, based on 1 article reviews
    ag825 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    93
    Tocris erbb inhibitor ag825
    Erbb Inhibitor Ag825, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erbb inhibitor ag825/product/Tocris
    Average 93 stars, based on 1 article reviews
    erbb inhibitor ag825 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Tocris tyrphostin ag825
    Neutrophils were incubated with media or a concentration range of gefitinib ( A ), lapatinib ( A ), sapatinib ( A ), CP-724714 ( B ), erbstatin (Erb, C ) or tyrphostin <t>AG825</t> (Tyr, D ) for 6 hr. Stars represent significant difference compared to DMSO control (indicated by ‘0’ in B-D). Neutrophils from COPD patients (open bars) and age-matched healthy control subjects (black bars) were incubated with DMSO or a concentration range of erbstatin ( E ) or tyrphostin AG825 ( F ) for 6 hr. Apoptosis was assessed by light microscopy. The data are expressed as mean percentage apoptosis ± SEM from 3 ( B, D ), 4 ( A,C ), 10 (E,F COPD), or 7 (E,F HC) independent experiments using different neutrophil donors. Statistical significances between control and inhibitor was calculated by one-way ANOVA with Dunnett’s post-test, indicated as *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
    Tyrphostin Ag825, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tyrphostin ag825/product/Tocris
    Average 93 stars, based on 1 article reviews
    tyrphostin ag825 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    Image Search Results


    Neutrophils were incubated with media or a concentration range of gefitinib ( A ), lapatinib ( A ), sapatinib ( A ), CP-724714 ( B ), erbstatin (Erb, C ) or tyrphostin AG825 (Tyr, D ) for 6 hr. Stars represent significant difference compared to DMSO control (indicated by ‘0’ in B-D). Neutrophils from COPD patients (open bars) and age-matched healthy control subjects (black bars) were incubated with DMSO or a concentration range of erbstatin ( E ) or tyrphostin AG825 ( F ) for 6 hr. Apoptosis was assessed by light microscopy. The data are expressed as mean percentage apoptosis ± SEM from 3 ( B, D ), 4 ( A,C ), 10 (E,F COPD), or 7 (E,F HC) independent experiments using different neutrophil donors. Statistical significances between control and inhibitor was calculated by one-way ANOVA with Dunnett’s post-test, indicated as *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Journal: eLife

    Article Title: Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation

    doi: 10.7554/eLife.50990

    Figure Lengend Snippet: Neutrophils were incubated with media or a concentration range of gefitinib ( A ), lapatinib ( A ), sapatinib ( A ), CP-724714 ( B ), erbstatin (Erb, C ) or tyrphostin AG825 (Tyr, D ) for 6 hr. Stars represent significant difference compared to DMSO control (indicated by ‘0’ in B-D). Neutrophils from COPD patients (open bars) and age-matched healthy control subjects (black bars) were incubated with DMSO or a concentration range of erbstatin ( E ) or tyrphostin AG825 ( F ) for 6 hr. Apoptosis was assessed by light microscopy. The data are expressed as mean percentage apoptosis ± SEM from 3 ( B, D ), 4 ( A,C ), 10 (E,F COPD), or 7 (E,F HC) independent experiments using different neutrophil donors. Statistical significances between control and inhibitor was calculated by one-way ANOVA with Dunnett’s post-test, indicated as *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Article Snippet: C57BL/6 mice (female, 9–10 weeks old) were nebulised with LPS (3 mg per group of 8 mice) ( Pseudomonas aeruginosa , Sigma-Aldrich) and immediately injected intraperitoneally (i.p.) with either Tyrphostin AG825 (Tocris Bioscience) at 20 mg/Kg in 10% DMSO v/v in vegetable oil (eight mice, treatment group) or an equivalent volume of 10% DMSO v/v in vegetable oil (eight mice, control group) ( ; ).

    Techniques: Incubation, Concentration Assay, Control, Light Microscopy

    Neutrophils were incubated with DMSO or 20 µM or 40 µM erbstatin (Erb, A and B ) or tyrphostin AG825 (Tyr, C ) for 6 hr. Apoptosis was assessed by Annexin V/TO-PRO-3 staining by flow cytometry and the percentage apoptosis calculated as Annexin V single plus Annexin V/TO-PRO-3 dual positive events. ( A ) Representative quadrant plot of Erbstatin-treated neutrophils showing distribution of Annexin V and TO-PRO-3 positive events. ( D–E ) Neutrophils were incubated with DMSO or Erbstatin [40 µM] in the presence or absence of the pan caspase inhibitor, Q-VD-OPh [1 µM] for 6 hr ( D ) or 20 hr ( E ). Apoptosis was assessed by light microscopy. The data are expressed as mean percentage apoptosis ± SEM from 3 ( B ), 4 (C and E), or 5 ( D ) independent experiments. Statistical differences were calculated by one-way ANOVA (with Dunnett’s post test ( B–C ) and two-way ANOVA with Sidak ( D–E ) post-tests) and indicated as *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.

    Journal: eLife

    Article Title: Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation

    doi: 10.7554/eLife.50990

    Figure Lengend Snippet: Neutrophils were incubated with DMSO or 20 µM or 40 µM erbstatin (Erb, A and B ) or tyrphostin AG825 (Tyr, C ) for 6 hr. Apoptosis was assessed by Annexin V/TO-PRO-3 staining by flow cytometry and the percentage apoptosis calculated as Annexin V single plus Annexin V/TO-PRO-3 dual positive events. ( A ) Representative quadrant plot of Erbstatin-treated neutrophils showing distribution of Annexin V and TO-PRO-3 positive events. ( D–E ) Neutrophils were incubated with DMSO or Erbstatin [40 µM] in the presence or absence of the pan caspase inhibitor, Q-VD-OPh [1 µM] for 6 hr ( D ) or 20 hr ( E ). Apoptosis was assessed by light microscopy. The data are expressed as mean percentage apoptosis ± SEM from 3 ( B ), 4 (C and E), or 5 ( D ) independent experiments. Statistical differences were calculated by one-way ANOVA (with Dunnett’s post test ( B–C ) and two-way ANOVA with Sidak ( D–E ) post-tests) and indicated as *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.

    Article Snippet: C57BL/6 mice (female, 9–10 weeks old) were nebulised with LPS (3 mg per group of 8 mice) ( Pseudomonas aeruginosa , Sigma-Aldrich) and immediately injected intraperitoneally (i.p.) with either Tyrphostin AG825 (Tocris Bioscience) at 20 mg/Kg in 10% DMSO v/v in vegetable oil (eight mice, treatment group) or an equivalent volume of 10% DMSO v/v in vegetable oil (eight mice, control group) ( ; ).

    Techniques: Incubation, Staining, Flow Cytometry, Light Microscopy

    Neutrophils were incubated with DMSO, Erbstatin [Erb, 40 µM] ( A ) or tyrphostin AG825 [Tyr, 50 µM] ( B ) in the presence of DMSO or N 6 -MB-cAMP [500 µM and 1 mM] for 20 hr. Neutrophils isolated from COPD patients were incubated with DMSO or tyrphostin AG825 [50 µM] in the presence of DMSO or N 6 -MB-cAMP [500 µM] for 20 hr ( C ). Neutrophils isolated from COPD patients and age-matched healthy control subjects (HC) were incubated with DMSO, erbstatin ( D ) [20, 40 µM] or tyrphostin AG825 ( E ) [25, 50 µM] in the presence or absence of GMCSF [50 u/mL] for 20 hr. Apoptosis was assessed by light microscopy. The data are expressed as mean percentage apoptosis ± SEM from 4 to 6 independent experiments. ( F ) Neutrophils were incubated with DMSO or tyrphostin AG825 [Tyr, 50 µM] for 60 min before the addition of GMCSF [50 u/mL] for 15 or 30 mins. ( G ) Neutrophils were incubated with DMSO, tyrphostin AG825 [50 µM] for 60 min before the addition of GMCSF [50 u/mL] for a further 7 hr. Cells were lysed, subjected to SDS-PAGE electrophoresis and membranes probed for p-AKT, Mcl-1 or loading controls, AKT and P38. Images are representative of 3 independent experiments. Charts show densitometric values of 3 individual immunoblots and are expressed as a ratio of target (p-AKT or Mcl-1) over loading control (AKT or P38, respectively). Statistically significant differences were calculated by one-way ANOVA with Sidak post-test ( A–C, F–G ) or two-way ANOVA with Sidak post-test ( D–E ) and indicated as *p<0.05, **p<0.01, ***p<0.001.

    Journal: eLife

    Article Title: Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation

    doi: 10.7554/eLife.50990

    Figure Lengend Snippet: Neutrophils were incubated with DMSO, Erbstatin [Erb, 40 µM] ( A ) or tyrphostin AG825 [Tyr, 50 µM] ( B ) in the presence of DMSO or N 6 -MB-cAMP [500 µM and 1 mM] for 20 hr. Neutrophils isolated from COPD patients were incubated with DMSO or tyrphostin AG825 [50 µM] in the presence of DMSO or N 6 -MB-cAMP [500 µM] for 20 hr ( C ). Neutrophils isolated from COPD patients and age-matched healthy control subjects (HC) were incubated with DMSO, erbstatin ( D ) [20, 40 µM] or tyrphostin AG825 ( E ) [25, 50 µM] in the presence or absence of GMCSF [50 u/mL] for 20 hr. Apoptosis was assessed by light microscopy. The data are expressed as mean percentage apoptosis ± SEM from 4 to 6 independent experiments. ( F ) Neutrophils were incubated with DMSO or tyrphostin AG825 [Tyr, 50 µM] for 60 min before the addition of GMCSF [50 u/mL] for 15 or 30 mins. ( G ) Neutrophils were incubated with DMSO, tyrphostin AG825 [50 µM] for 60 min before the addition of GMCSF [50 u/mL] for a further 7 hr. Cells were lysed, subjected to SDS-PAGE electrophoresis and membranes probed for p-AKT, Mcl-1 or loading controls, AKT and P38. Images are representative of 3 independent experiments. Charts show densitometric values of 3 individual immunoblots and are expressed as a ratio of target (p-AKT or Mcl-1) over loading control (AKT or P38, respectively). Statistically significant differences were calculated by one-way ANOVA with Sidak post-test ( A–C, F–G ) or two-way ANOVA with Sidak post-test ( D–E ) and indicated as *p<0.05, **p<0.01, ***p<0.001.

    Article Snippet: C57BL/6 mice (female, 9–10 weeks old) were nebulised with LPS (3 mg per group of 8 mice) ( Pseudomonas aeruginosa , Sigma-Aldrich) and immediately injected intraperitoneally (i.p.) with either Tyrphostin AG825 (Tocris Bioscience) at 20 mg/Kg in 10% DMSO v/v in vegetable oil (eight mice, treatment group) or an equivalent volume of 10% DMSO v/v in vegetable oil (eight mice, control group) ( ; ).

    Techniques: Incubation, Isolation, Control, Light Microscopy, SDS Page, Electrophoresis, Western Blot

    C57BL/6 mice were nebulized with LPS and immediately injected intraperitoneally with either 10% DMSO (control, n = 8) or 20 mg/Kg tyrphostin AG825 (Tyr, n = 8). After 48 hr the mice were sacrificed and subjected to bronchoalveolar lavage. Percentage neutrophils (A, closed icons) and macrophages (A, open icons) and absolute numbers of neutrophils (B, closed icons) and macrophages (B, open icons) in BAL were calculated by haemocytometer and light microscopy. ( C ) Percentage neutrophil apoptosis (circles) and percentage neutrophil apoptosis calculated by also including numbers of apoptotic inclusions visualised within macrophages (triangles) was assessed by light microscopy. ( D ) Macrophages containing one or more apoptotic inclusions expressed as a percentage of all macrophages. Light microscopy image showing apoptotic inclusions within macrophages as indicated by black arrows ( E ). C57BL/6 mice were injected i.p. with 1 mg zymosan and 4 hr later injected i.p. with 20 mg/Kg tyrphostin AG825 (Tyr, n = 5) or 10% DMSO (Control, n = 5). At 20 hr mice were sacrificed and subjected to peritoneal lavage. ( F ) WBC, neutrophils and macrophages in blood were measured by a Sysmex cell counter. Total cells in peritoneal lavage were counted by flow cytometry ( G ) and KC, IL-6 ( H ) and IgM ( I ) measured in lavage by ELISA. At least two independent experimental replicates each processing 1–3 mice/group were performed. Statistical significance was calculated by Mann–Whitney U test ( A–D and G–I ) or one-way ANOVA with Sidak post-test ( F ) and indicated as *p<0.05, **p<0.01, ***p<0.001.

    Journal: eLife

    Article Title: Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation

    doi: 10.7554/eLife.50990

    Figure Lengend Snippet: C57BL/6 mice were nebulized with LPS and immediately injected intraperitoneally with either 10% DMSO (control, n = 8) or 20 mg/Kg tyrphostin AG825 (Tyr, n = 8). After 48 hr the mice were sacrificed and subjected to bronchoalveolar lavage. Percentage neutrophils (A, closed icons) and macrophages (A, open icons) and absolute numbers of neutrophils (B, closed icons) and macrophages (B, open icons) in BAL were calculated by haemocytometer and light microscopy. ( C ) Percentage neutrophil apoptosis (circles) and percentage neutrophil apoptosis calculated by also including numbers of apoptotic inclusions visualised within macrophages (triangles) was assessed by light microscopy. ( D ) Macrophages containing one or more apoptotic inclusions expressed as a percentage of all macrophages. Light microscopy image showing apoptotic inclusions within macrophages as indicated by black arrows ( E ). C57BL/6 mice were injected i.p. with 1 mg zymosan and 4 hr later injected i.p. with 20 mg/Kg tyrphostin AG825 (Tyr, n = 5) or 10% DMSO (Control, n = 5). At 20 hr mice were sacrificed and subjected to peritoneal lavage. ( F ) WBC, neutrophils and macrophages in blood were measured by a Sysmex cell counter. Total cells in peritoneal lavage were counted by flow cytometry ( G ) and KC, IL-6 ( H ) and IgM ( I ) measured in lavage by ELISA. At least two independent experimental replicates each processing 1–3 mice/group were performed. Statistical significance was calculated by Mann–Whitney U test ( A–D and G–I ) or one-way ANOVA with Sidak post-test ( F ) and indicated as *p<0.05, **p<0.01, ***p<0.001.

    Article Snippet: C57BL/6 mice (female, 9–10 weeks old) were nebulised with LPS (3 mg per group of 8 mice) ( Pseudomonas aeruginosa , Sigma-Aldrich) and immediately injected intraperitoneally (i.p.) with either Tyrphostin AG825 (Tocris Bioscience) at 20 mg/Kg in 10% DMSO v/v in vegetable oil (eight mice, treatment group) or an equivalent volume of 10% DMSO v/v in vegetable oil (eight mice, control group) ( ; ).

    Techniques: Injection, Control, Light Microscopy, Flow Cytometry, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY

    Tail fin transection was performed as indicated by the red line ( A , upper image). Zebrafish larvae ( mpx :GFP) were pre-treated at two dpf with DMSO, tyrphostin AG825 [Tyr, 10 µM] ( B , minimum n = 28 larvae per condition), or CP-724714 [10 µM] ( C , minimum n = 42 larvae per condition) for 16 hr followed by injury. egfra and erbb2 crispants were generated and injured at two dpf ( D , minimum n = 36 larvae per condition). The number of neutrophils at the site of injury was determined at 4 and 8 hpi by counting GFP-positive neutrophils. To enumerate neutrophils across the whole body, uninjured inhibitor treated larvae (three dpf) ( E , minimum n = 23 larvae per condition) or crispants (two dpf) ( F , minimum n = 28 larvae per condition) were imaged by fluorescent microscopy (A, lower image). Apoptosis was measured at the site of injury after 8 hr by TSA and TUNEL double staining ( G ) (white arrow indicates TUNEL positive neutrophil, scale bar 10 μM) of mpx: GFP tyrphostin AG825 [Tyr, 10 µM] or CP-724714 [10 µM] treated larvae at three dpf ( H , minimum n = 35 larvae per condition). Uninjured inhibitor treated larvae were assessed for neutrophil apoptosis in the CHT at three dpf ( I , minimum n = 27 larvae per group). Apoptosis at the tail fin injury site of egfra erbb2 crispants at two dpf was also measured at eight hpi ( J , minimum n = 26 larvae per group). All data collated from at least three independent experiments, displayed as mean ± SEM. Each icon shows one data point from one individual larvae. Statistically significant differences were calculated by two-way ANOVA with Sidak post-test ( B–D ) or one-way ANOVA with Dunnett’s post-test(E), Students’ t-test ( F ), Kruskal-Wallis test with Dunn’s post-test ( H–I ) or Mann-Whitney U test ( J ), and indicated as *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Journal: eLife

    Article Title: Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation

    doi: 10.7554/eLife.50990

    Figure Lengend Snippet: Tail fin transection was performed as indicated by the red line ( A , upper image). Zebrafish larvae ( mpx :GFP) were pre-treated at two dpf with DMSO, tyrphostin AG825 [Tyr, 10 µM] ( B , minimum n = 28 larvae per condition), or CP-724714 [10 µM] ( C , minimum n = 42 larvae per condition) for 16 hr followed by injury. egfra and erbb2 crispants were generated and injured at two dpf ( D , minimum n = 36 larvae per condition). The number of neutrophils at the site of injury was determined at 4 and 8 hpi by counting GFP-positive neutrophils. To enumerate neutrophils across the whole body, uninjured inhibitor treated larvae (three dpf) ( E , minimum n = 23 larvae per condition) or crispants (two dpf) ( F , minimum n = 28 larvae per condition) were imaged by fluorescent microscopy (A, lower image). Apoptosis was measured at the site of injury after 8 hr by TSA and TUNEL double staining ( G ) (white arrow indicates TUNEL positive neutrophil, scale bar 10 μM) of mpx: GFP tyrphostin AG825 [Tyr, 10 µM] or CP-724714 [10 µM] treated larvae at three dpf ( H , minimum n = 35 larvae per condition). Uninjured inhibitor treated larvae were assessed for neutrophil apoptosis in the CHT at three dpf ( I , minimum n = 27 larvae per group). Apoptosis at the tail fin injury site of egfra erbb2 crispants at two dpf was also measured at eight hpi ( J , minimum n = 26 larvae per group). All data collated from at least three independent experiments, displayed as mean ± SEM. Each icon shows one data point from one individual larvae. Statistically significant differences were calculated by two-way ANOVA with Sidak post-test ( B–D ) or one-way ANOVA with Dunnett’s post-test(E), Students’ t-test ( F ), Kruskal-Wallis test with Dunn’s post-test ( H–I ) or Mann-Whitney U test ( J ), and indicated as *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    Article Snippet: C57BL/6 mice (female, 9–10 weeks old) were nebulised with LPS (3 mg per group of 8 mice) ( Pseudomonas aeruginosa , Sigma-Aldrich) and immediately injected intraperitoneally (i.p.) with either Tyrphostin AG825 (Tocris Bioscience) at 20 mg/Kg in 10% DMSO v/v in vegetable oil (eight mice, treatment group) or an equivalent volume of 10% DMSO v/v in vegetable oil (eight mice, control group) ( ; ).

    Techniques: Generated, Microscopy, TUNEL Assay, Double Staining, MANN-WHITNEY